Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul;125(7):679-687.e1.
doi: 10.1016/j.amjmed.2011.09.033. Epub 2012 May 23.

Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008

Yanyan Zhu  1 , Bhavik J Pandya, Hyon K Choi
Affiliations

Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008

Yanyan Zhu et al. Am J Med. 2012 Jul.

Abstract

Purpose: The objective of this study was to estimate the latest prevalence of major comorbidities associated with gout and hyperuricemia in the US based on a recent, nationally representative sample of US men and women.

Methods: Using data from 5707 participants aged 20 years and older in the National Health and Nutrition Examination Survey 2007-2008, we calculated the national prevalence and population estimates of major comorbidities according to gout status and various hyperuricemia levels, compared with those without these conditions. Case definitions of gout and comorbidities were based on an affirmative answer to a question that asked whether a physician or a health professional had diagnosed the corresponding condition.

Results: Among these individuals with gout, 74% (6.1 million) had hypertension, 71% (5.5 million) had chronic kidney disease stage ≥2, 53% (4.3 million) were obese, 26% (2.1 million) had diabetes, 24% (2.0 million) had nephrolithiasis, 14% (1.2 million) had myocardial infarction, 11% (0.9 million) had heart failure, and 10% (0.9 million) had suffered a stroke. These proportions were substantially higher than those among individuals without gout (all P-values <.67). With increasing levels of hyperuricemia, there were graded increases in the prevalences of these comorbidities. In the top category (serum urate ≥10 mg/dL), 86% of subjects had chronic kidney disease stage ≥2, 66% had hypertension, 65% were obese, 33% had heart failure, 33% had diabetes, 23% had myocardial infarction, and 12% had stroke. These prevalences were 3-33 times higher than those in the lowest serum urate category (<4 mg/dL). Sex-specific odds ratios tended to be larger among women than men, and the overall comorbidity prevalence was highest among individuals with both gout and hyperuricemia.

Conclusions: These findings from the latest nationally representative data highlight remarkable prevalences and population estimates of comorbidities of gout and hyperuricemia in the US. Appropriate preventive and management measures of these comorbidities should be implemented in gout management, with a preference to strategies that can improve gout and comorbidities together.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Association between gout and cancers: A systematic review and meta-analysis.
    Tian L, Wang Y, Zhang Y, Tian L, Wang H. Tian L, et al. Medicine (Baltimore). 2024 Oct 25;103(43):e40234. doi: 10.1097/MD.0000000000040234. Medicine (Baltimore). 2024. PMID: 39470515 Free PMC article.
  • Comorbidities confound metabolomics studies of human disease.
    Jaagura M, Kronberg J, Reigo A, Aasmets O, Nikopensius T, Võsa U, Bomba L; Estonian Biobank research team; Estrada K, Wuster A, Esko T, Org E. Jaagura M, et al. Sci Rep. 2024 Oct 22;14(1):24810. doi: 10.1038/s41598-024-75556-1. Sci Rep. 2024. PMID: 39438584 Free PMC article.
  • Trigger Warning: How Modern Diet, Lifestyle, and Environment Pull the Trigger on Autosomal Dominant Polycystic Kidney Disease Progression.
    Messing M, Torres JA, Holznecht N, Weimbs T. Messing M, et al. Nutrients. 2024 Sep 27;16(19):3281. doi: 10.3390/nu16193281. Nutrients. 2024. PMID: 39408247 Free PMC article. Review.
  • A genome-wide association analysis reveals new pathogenic pathways in gout.
    Major TJ, Takei R, Matsuo H, Leask MP, Sumpter NA, Topless RK, Shirai Y, Wang W, Cadzow MJ, Phipps-Green AJ, Li Z, Ji A, Merriman ME, Morice E, Kelley EE, Wei WH, McCormick SPA, Bixley MJ, Reynolds RJ, Saag KG, Fadason T, Golovina E, O'Sullivan JM, Stamp LK, Dalbeth N, Abhishek A, Doherty M, Roddy E, Jacobsson LTH, Kapetanovic MC, Melander O, Andrés M, Pérez-Ruiz F, Torres RJ, Radstake T, Jansen TL, Janssen M, Joosten LAB, Liu R, Gaal OI, Crişan TO, Rednic S, Kurreeman F, Huizinga TWJ, Toes R, Lioté F, Richette P, Bardin T, Ea HK, Pascart T, McCarthy GM, Helbert L, Stibůrková B, Tausche AK, Uhlig T, Vitart V, Boutin TS, Hayward C, Riches PL, Ralston SH, Campbell A, MacDonald TM; FAST Study Group; Nakayama A, Takada T, Nakatochi M, Shimizu S, Kawamura Y, Toyoda Y, Nakaoka H, Yamamoto K, Matsuo K, Shinomiya N, Ichida K; Japan Gout Genomics Consortium; Lee C; Asia Pacific Gout Consortium; Bradbury LA, Brown MA, Robinson PC, Buchanan RRC, Hill CL, Lester S, Smith MD, Rischmueller M, Choi HK, Stahl EA, Miner JN, Solomon DH, Cui J, Giacomini KM, Brackman DJ, Jorgenson EM; GlobalGout Genetics Consortium; Liu H, Susztak K; 23andMe Research Team; Shringarpure S, So A, Okada Y, Li C, Shi Y,… See abstract for full author list ➔ Major TJ, et al. Nat Genet. 2024 Oct 15. doi: 10.1038/s41588-024-01921-5. Online ahead of print. Nat Genet. 2024. PMID: 39406924
  • Cardiovascular risk according to genetic predisposition to gout, lifestyle and metabolic health across prospective European and Korean cohorts.
    Moon KW, Jung SH, Do H, Son CN, Kim J, Nam Y, Yun JS, Park WY, Won HH, Kim D. Moon KW, et al. RMD Open. 2024 Oct 8;10(4):e004552. doi: 10.1136/rmdopen-2024-004552. RMD Open. 2024. PMID: 39379299 Free PMC article.
See all "Cited by" articles

Publication types

LinkOut - more resources